CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570) Rare Diseases (230)
Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's drug development programs are rooted in the principle...Show all
Company (IPO / Went public)
Phone: 617-349-1971
One Kendall Square
Bldg 1400E Suite B14202
Cambridge, 02139
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Catabasis Pharmaceuticals | $103.5M | Jun 25, 2015 |
| CGI Pharmaceuticals | $61.1M | Jun 25, 2010 |
| Xanthus Pharmaceuticals | $63.8M | Jun 9, 2008 |
| See all 17 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Fatty acid cysteamine conjugates and their use as activators of autophagy | Nov 25, 2015 | Apr 09, 2019 | Patent |
| Fatty acid niacin conjugates and their uses | Jun 25, 2015 | Nov 14, 2017 | Patent |
| Fatty acid niacin conjugates and their uses | Jun 25, 2015 | Nov 14, 2017 | Patent |
| Fatty acid acylated salicylates and their uses | Jul 20, 2015 | Jul 18, 2017 | Patent |
| Niacin conjugated fatty acid mixtures and their uses | Jan 26, 2015 | Nov 08, 2016 | Patent |
